Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1-266.
2. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease KDOQI; National Kidney Foundation. Am J Kidney Dis 2006;47:S11–145.
3. Zhao Y, Zhang LL, Ding FX, Cao P, Qi YY, Wang J. Pin1 and secondary hyperparathyroidism of chronic kidney disease: gene polymorphisms and protein levels. Ren Fail. 2017;39(1):159–65.
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;76(S113):S1-130.
5. Nechama M, Uchida T, Mor Yosef-Levi I, Silver J, Naveh-Many T. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest. 2009;119(10):3102–14.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献